Exome Asset Management LLC / SRPT
Exome Asset Management LLC’s Sarepta Therapeutics Inc Position
Does Exome Asset Management LLC own Sarepta Therapeutics Inc (SRPT)? Not currently — the last reported position was 32.9K shares worth $5M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$5M
Q2 2024
Shares
32.9K
% of Portfolio
+4.53%
Quarters Held
1
position exited
Position History SRPT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2024 | 32.9K | $5M | +4.53% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Exome Asset Management LLC’s full portfolio or all institutional holders of SRPT.